Expression of cholesteryl ester transfer protein in human atherosclerotic lesions and its implication in reverse cholesterol transport

Atherosclerosis

Volumn 159, Issue 1, 2001, Pages 67-75

  Zhang, Zhongyan ^a   Yamashita, Shizuya ^a   Hirano, Ken ichi ^a   Nakagawa Toyama, Yumiko ^a   Matsuyama, Akifumi ^a   Nishida, Makoto ^a   Sakai, Naohiko ^a   Fukasawa, Masayoshi ^b   Arai, Hiroyuki ^b   Miyagawa, Jun ichiro ^a   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Atherosclerosis; CETP; CETP deficiency; Cholesterol efflux; Macrophages; Reverse cholesterol transport

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; COMPLEMENTARY DNA; HIGH DENSITY LIPOPROTEIN;

ADULT; AGED; ANIMAL CELL; AORTA ATHEROSCLEROSIS; ARTERY WALL; ARTICLE; CELL POPULATION; CERCOPITHECIDAE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DERIVATIZATION; EFFUSION; FOAM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIPID TRANSPORT; MACROPHAGE; MASS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; AORTA; ARTERIOSCLEROSIS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CELLS, CULTURED; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEINS; CORONARY VESSELS; COS CELLS; FOAM CELLS; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOPROTEINS, HDL; MACROPHAGES; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; TRANSFECTION;

EID: 0034751739     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00490-7     Document Type: Article

References (35)

1. Plasma high-density-lipoprotein-concentration and development of ischemic heart disease
2. Molecular mechanism of reverse cholesterol transport
3. Cell cholesterol efflux: Integration of old and new observations provides new insights
4. Molecular genetics of plasma cholesteryl ester transfer protein
5. Plasma cholesteryl ester transfer protein and high density lipoproteins: New insights from molecular genetic studies
6. Pros and cons of inhibiting cholesteryl ester transfer protein
7. Reverse cholesterol transport; a review of the process and its clinical implications
8. Small polydisperse low density lipoproteins in familial hyperalphalipoproteinemia with complete deficiency of cholesteryl ester transfer activity
9. Increased high density lipoprotein levels caused by a common cholesteryl ester transfer protein gene mutation
10. Detection of two species of low density lipoprotein particles in cholesteryl ester transfer protein deficiency
11. Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency
12. Total deficiency of plasma cholesteryl ester transfer protein in subjects homozygous and heterozygous for the intron 14 splicing defect
13. A novel nonsense mutation in the cholesteryl ester transfer protein gene causing marked hyperalphalipoproteinemia
14. A missense mutation in the cholesterylester transfer protein gene with possible dominant effects on plasma high density lipoproteins
15. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity
16. Astroglial localization of cholesteryl ester transfer protein in normal and Alzheimer's disease brain tissues
17. Oxidized low-density lipoprotein increases, and interferon-g decreases, the expression of CD36 in human monocyte-derived macrophages
18. Expression of human scavenger receptor class B type I in cultured human monocyte-derived macrophages and atherosclerotic lesions
19. Exon 10 skipping caused by intron 10 splice donor site mutation in cholesteryl ester transfer protein gene results in abnormal downstream splice site selection
20. Scavenger receptor BI (SR-BI) mediates free cholesterol flux independently of HDL tethering to the cell surface
21. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor
22. Large and cholesteryl ester-rich high density lipoproteins in cholesteryl ester transfer protein deficiency can not prevent macrophages from cholesterol accumulation induced by acetylated low density lipoproteins
23. Very high density lipoproteins induced by plasma cholesteryl ester transfer protein (CETP) have a potent antiatherogenic function
24. Atherosclerotic disease in marked hyperalphalipoproteinemia: Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase
25. The implications of the structure of the bactericidal/permeability-increasing protein on the lipid-transfer function of the cholesteryl ester transfer protein
26. Physical and kinetic characterization of recombinant human cholesteryl ester transfer protein
27. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
28. Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and Abc1-deficient mice
29. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux
30. Identification of a GPI-anchored type HDL-binding protein on human macrophages
31. Decreased expression of a member of the Rho GTPase family, Cdc42Hs, in cells from Tangier disease. The small G protein may play a role in cholesterol efflux
32. Mechanism of the cholesteryl ester transfer protein-mediated uptake of high density lipoprotein cholesteryl esters by Hep G2 cells
33. Cholesteryl ester transfer protein mediates selective uptake of high density lipoprotein cholesteryl esters by human adipose tissue
34. Expression of macrophage (Mφ) scavenger receptor, CD36, in cultured human aortic smooth muscle cells in association with expression of peroxisome prolif-erator activated receptor-gamma, which regulates gain of Mφ-like phenotype in vitro, and its implication in atherogenesis
35. Cholesteryl ester transfer protein deficiency is substantially atherogenic. Measurement of pulse wave velocity and quantification of carotid and aortic plaques